nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB3—nicotine dependence	0.0464	0.0571	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA6—nicotine dependence	0.044	0.0541	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB3—nicotine dependence	0.0396	0.0486	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA6—nicotine dependence	0.0375	0.0461	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNB3—nicotine dependence	0.0369	0.0453	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA6—nicotine dependence	0.035	0.043	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNB3—nicotine dependence	0.0326	0.0401	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA6—nicotine dependence	0.0309	0.038	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB4—nicotine dependence	0.0305	0.0375	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—nicotine dependence	0.0284	0.0349	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB4—nicotine dependence	0.026	0.0319	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNB4—nicotine dependence	0.0242	0.0298	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—nicotine dependence	0.0242	0.0297	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—nicotine dependence	0.0231	0.0284	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—nicotine dependence	0.0225	0.0277	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNB4—nicotine dependence	0.0214	0.0263	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNB2—nicotine dependence	0.0204	0.025	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA5—nicotine dependence	0.0199	0.0245	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—nicotine dependence	0.0197	0.0242	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—nicotine dependence	0.0185	0.0227	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—nicotine dependence	0.0184	0.0226	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNB2—nicotine dependence	0.0173	0.0213	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA3—nicotine dependence	0.0162	0.02	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNB2—nicotine dependence	0.0162	0.0199	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—nicotine dependence	0.0157	0.0193	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—nicotine dependence	0.0147	0.018	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNB2—nicotine dependence	0.0143	0.0176	CbGpPWpGaD
Gallamine Triethiodide—Upset stomach—Varenicline—nicotine dependence	0.0134	0.0723	CcSEcCtD
Gallamine Triethiodide—Cyst—Varenicline—nicotine dependence	0.0132	0.0708	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—nicotine dependence	0.013	0.016	CbGpPWpGaD
Gallamine Triethiodide—Endocrine disorder—Varenicline—nicotine dependence	0.0106	0.0571	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Varenicline—nicotine dependence	0.0103	0.0554	CcSEcCtD
Gallamine Triethiodide—Tenderness—Varenicline—nicotine dependence	0.0101	0.0543	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Varenicline—nicotine dependence	0.00856	0.046	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Varenicline—nicotine dependence	0.0075	0.0403	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0064	0.0344	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Varenicline—nicotine dependence	0.00584	0.0314	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Varenicline—nicotine dependence	0.00572	0.0307	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Varenicline—nicotine dependence	0.0053	0.0285	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00517	0.00635	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.0049	0.00602	CbGpPWpGaD
Gallamine Triethiodide—Hypoaesthesia—Varenicline—nicotine dependence	0.0044	0.0237	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Varenicline—nicotine dependence	0.00414	0.0222	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Varenicline—nicotine dependence	0.00411	0.0221	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00389	0.00477	CbGpPWpGaD
Gallamine Triethiodide—Dysgeusia—Varenicline—nicotine dependence	0.00377	0.0203	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00368	0.00453	CbGpPWpGaD
Gallamine Triethiodide—Anaemia—Varenicline—nicotine dependence	0.00356	0.0191	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00354	0.00435	CbGpPWpGaD
Gallamine Triethiodide—Angioedema—Varenicline—nicotine dependence	0.00352	0.0189	CcSEcCtD
Gallamine Triethiodide—Malaise—Varenicline—nicotine dependence	0.00347	0.0187	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0034	0.00417	CbGpPWpGaD
Gallamine Triethiodide—Cough—Varenicline—nicotine dependence	0.00336	0.0181	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Varenicline—nicotine dependence	0.00328	0.0176	CcSEcCtD
Gallamine Triethiodide—Chest pain—Varenicline—nicotine dependence	0.00328	0.0176	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00326	0.0175	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00316	0.00388	CbGpPWpGaD
Gallamine Triethiodide—Thrombocytopenia—Varenicline—nicotine dependence	0.00308	0.0165	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Varenicline—nicotine dependence	0.00307	0.0165	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Varenicline—nicotine dependence	0.00305	0.0164	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNB3—nicotine dependence	0.00298	0.00366	CbGpPWpGaD
Gallamine Triethiodide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00286	0.0154	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA6—nicotine dependence	0.00282	0.00347	CbGpPWpGaD
Gallamine Triethiodide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00271	0.0146	CcSEcCtD
Gallamine Triethiodide—Fatigue—Varenicline—nicotine dependence	0.00271	0.0146	CcSEcCtD
Gallamine Triethiodide—Pain—Varenicline—nicotine dependence	0.00269	0.0144	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00266	0.00327	CbGpPWpGaD
Gallamine Triethiodide—Feeling abnormal—Varenicline—nicotine dependence	0.00259	0.0139	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00257	0.00316	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00255	0.00314	CbGpPWpGaD
Gallamine Triethiodide—Urticaria—Varenicline—nicotine dependence	0.0025	0.0134	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Varenicline—nicotine dependence	0.00249	0.0134	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Varenicline—nicotine dependence	0.00249	0.0134	CcSEcCtD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0024	0.00295	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00237	0.00292	CbGpPWpGaD
Gallamine Triethiodide—Hypersensitivity—Varenicline—nicotine dependence	0.00232	0.0124	CcSEcCtD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00228	0.0028	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00227	0.00278	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Varenicline—nicotine dependence	0.00226	0.0121	CcSEcCtD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00224	0.00275	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Varenicline—nicotine dependence	0.00222	0.012	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Varenicline—nicotine dependence	0.00215	0.0116	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00206	0.00253	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—GABRA4—nicotine dependence	0.00204	0.00251	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Varenicline—nicotine dependence	0.002	0.0107	CcSEcCtD
Gallamine Triethiodide—Rash—Varenicline—nicotine dependence	0.00198	0.0107	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Varenicline—nicotine dependence	0.00198	0.0106	CcSEcCtD
Gallamine Triethiodide—Headache—Varenicline—nicotine dependence	0.00197	0.0106	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNB4—nicotine dependence	0.00196	0.0024	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00194	0.00238	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00188	0.00231	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Varenicline—nicotine dependence	0.00187	0.01	CcSEcCtD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00184	0.00226	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA5—nicotine dependence	0.00182	0.00223	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00175	0.00215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00172	0.00212	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0017	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00165	0.00202	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00158	0.00194	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00155	0.0019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00153	0.00188	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA3—nicotine dependence	0.00148	0.00182	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00147	0.0018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00131	0.00161	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNB2—nicotine dependence	0.00131	0.0016	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00126	0.00155	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00121	0.00149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0012	0.00147	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—CHRNA4—nicotine dependence	0.00119	0.00146	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00113	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00107	0.00132	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00105	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00103	0.00126	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000957	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000924	0.00114	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.000917	0.00113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000873	0.00107	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.000807	0.000992	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000793	0.000974	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000733	0.000901	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000644	0.000791	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000597	0.000734	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000522	0.000642	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000512	0.000629	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000474	0.000583	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000465	0.000572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000432	0.000531	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.00041	0.000504	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.00039	0.000479	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000372	0.000457	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00037	0.000455	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000318	0.000391	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000282	0.000346	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.00028	0.000344	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00022	0.000271	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.00022	0.00027	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.0002	0.000246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000194	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000159	0.000196	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000145	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000137	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000131	0.000161	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000118	0.000145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRD2—nicotine dependence	8.54e-05	0.000105	CbGpPWpGaD
